Summary by Futu AI
ACEA PHARMACEUTICALS LIMITED FILED THE FOLLOWING DAY DISCLOSURE REPORT WITH THE HONG KONG STOCK EXCHANGE LIMITED ON FEBRUARY 5, 2024 DISCLOSING THE REPURCHASE OF THE COMPANY'S SHARES. According to the report, between 19 December 2023 and 5 February 2024, Song Pharmaceuticals made multiple share repurchases through the Hong Kong Stock Exchange, totaling 63,621,000 shares, representing 5.8522% of the total number of shares issued at that time. The last repurchase took place on February 5, 2024. The number of shares repurchased on that date was 750,000 shares at a price of HKD 1.59 to HKD 1.71 for a total payment of HKD 1,212,160. Following the repurchase, the total number of shares issued by Kai Pharma is 1,044,821,000 shares. The Company confirms that all repurchases have been approved by the Board of Directors and comply with the Listing Rules of the HKEX Main Board.